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1. Introduction
When designing a study, it is not uncommon for the outcome variable of interest to be dichotomous.
Unsurprisingly therefore, there is a long history of publications pertaining to the design of studies that
compare two binomial proportions. Whilst a normal approximation could be utilised for comparing
proportions, in the case of small samples this can lead to substantial inflation of the familywise error-rate
(FWER). Therefore, exact statistical methods are required, and one classical approach to this is Fisher’s
exact test (Fisher, 1935), sometimes also credited to Yates (1934) or Irwin (1935). Unfortunately, prior
to the advent of modern computing power this method was prohibitively computationally intensive, and
therefore the early literature contains several proposals for approximating the problem of sample size
determination (see, for example, Casagrande et al. (1978), Fleiss et al. (1980), and Ury and Fleiss
(1980)). Today, computational speed is no longer an issue, and exact methods are readily available, not
only for two-arm, but also multi-arm studies (Mehta and Patel, 1983; Mehta and Patel, 1986). Thus,
along with alternative exact methods, such as Barnard’s test (Barnard, 1945), Fisher’s exact test allows
for the effectual design and analysis of small fixed-sample studies with binary outcome variables.
Since Wald published his work on the sequential probability ratio test (Wald, 1945), there has been
substantial interest in study designs that allow for the interim assessment of hypotheses. Recently, for
logistical reasons, the focus of such research has typically been on group, rather than fully, sequential
designs. Indeed, much methodology now exists on this (see, for example, Jennison and Turnbull (2000)),
including recent extensions to multi-arm studies with normally distributed outcomes (Magirr et al., 2012).
This approach has also been demonstrated to be applicable asymptotically to binary outcome variables
(Jaki and Magirr, 2013).
Unfortunately, the drawbacks of utilising a normal approximation in small sample studies with binary
data persist in this sequential setting. Accordingly, recent proposals have included methods for the
design of two-stage multi-arm studiess, allowing early stopping to accept null hypotheses, that employ
exact binomial tests (Jung, 2008). Later, this methodology was extended in the case of two-arm designs
to allow early stopping to reject null hypotheses (Jung, 2013). However, this approach was demonstrated
to be highly conservative for certain values of the shared success probability across the design arms. To
attempt to resolve this in a two-arm setting, a recent paper presented a two-stage version of Fisher’s exact
test (Jung and Sargent, 2014). It was established that this design could on average more exhaustively
utilise the designated FWER.
Nonetheless, as stated, the design presented in Jung and Sargent (2014) was limited to two-arm stud-
ies only. Moreover, a functional form for the stopping boundaries at the interim analysis was assumed,
which may substantially reduce the chance the design will be more efficient than an approach based
on exact binomial tests. In this paper, we seek to address these limitations by presenting an optimised
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two-stage version of Fisher’s exact test applicable to multi-arm studies. Extension to a multi-arm domain
is of particular importance because of the noted advantages in terms of efficiency of comparing multiple
arms against a single control (Parmar et al., 2014). Furthermore, this study design scenario is becom-
ing increasingly common. For example, in clinical research, in many disease settings numerous novel
compounds are available for testing in phase II, and the primary outcome variable is typically a binary
response indicator. Whilst randomised trials are now being far more typically utilised in this setting
(Ivanova et al., 2016).
This paper will consist of the following sections. First we introduce the notation used in the paper in
Section 2.1. Following this, in Section 2.2, we summarise the previously proposed design based on exact
binomial tests. Our approach is then presented in Section 2.3. Throughout these sections, particular
focus is given to the requirements for achieving weak or strong control of the FWER. Then, in Section
2.4 we introduce a phase II clinical trial utilised as a motivating example. Our results are then detailed in
Section 3, before we conclude with a discussion of the advantages and disadvantages of the two considered
designs in Section 4.
2. Methods
2.1. Notation, hypotheses and analysis
Define the sets Na = {n ∈ N : n ≤ a} and N+a = Na\{0}. Then, we suppose that our study will have a
single (control) arm, indexed by k = 0, which will be compared to K ∈ N+ (experimental) arms, indexed
by k ∈ N+K , in a pairwise manner within a two-stage design. Denoting the success probability for each
arm k ∈ NK by pk, we test the following composite hypotheses
H0k : pk = p0, H1k : pk = p0 + δk, k ∈ N+K ,
where δk > 0 for k ∈ N+K . That is, if Yki ∈ N1 is the random variable describing the outcome from
experiment i in arm k, then P(Yki = 1) = pk for k ∈ N+K .
We allow early stopping to both reject and accept the null hypotheses, if so desired, assuming that
the rejection of any null hypothesis at the first analysis leads to the termination of the whole study. Note
that methodology for a design which terminates the study only when a decision has been made for every
null hypothesis could be specified similarly.
We assume that control of the FWER, the probability of one or more incorrect rejections of null
hypotheses, is desired to some maximal level α ∈ (0, 1). We discuss criteria for both weak and strong
control of the FWER. Moreover, we suppose the experiment must have a familywise power (FWP) of at
least 1 − β ∈ (0, 1) when pk = p0 + δk for k ∈ N+K . That is, we design the experiment to have power
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at reject at least one of the H0k, when H1k is true for k ∈ N+K . Note however that power to reject a
particular null hypothesis could be achieved similarly.
In testing our hypotheses, we will make repeated reference to the odds ratios θk given by
θk =
pk(1− p0)
p0(1− pk) , k ∈ N
+
K .
Furthermore, we will make use of the vectors p = (p0, . . . , pK)
>, θ = (θ1, . . . , θK)>, and δ =
(0, δ1, . . . , δK)
T . To indicate the θ implied by a particular p using the relationship given above, we
use the notation θ(p).
In stage one, we suppose that n experiments are to be conducted in the control arm, for some n ∈ N+.
Then, we specify parameters rCj ∈ R+ ∪{0} such that the total number of experiments conducted in the
control arm by the completion of stage j ∈ N2 is rCjn ∈ N. Similarly, we designate values rEj ∈ R+∪{0}
such that the total number of experiments conducted in each arm k ∈ N+K still present in the experiment
is rEjn ∈ N. Here, we retain the notion of a stage 0 to simplify the expressions that follow. To facilitate
the dropping of one or more arms after stage one, we denote by rkjn ∈ N the actual number of trials
conducted in arm k ∈ NK after stage j ∈ N2. Note therefore that rC0 = rE0 = 0 and rC1 = 1, the other
rCj and rEj will be assumed to be pre-specified. In contrast, n will be determined based on the studies’
power requirements. One could however choose to search numerically for advantageous values of the rCj
and rEj , according to some designated optimality criteria, if desired.
Next, we denote by Xkj the unknown total number of successes in arm k ∈ NK in stage j ∈ N+2 , and
by xkj its corresponding observed value. Thus Xkj ∼ B{n(rkj − rkj−1), pk}.
Then, in both the Fisher exact and exact binomial test frameworks, at each interim analysis j ∈ N+2 ,
we employ the following test statistics
Tkj =
j∑
m=1
xkm −
j∑
m=1
x0m, k ∈ N+K . (2.1)
Finally, in what follows it will be convenient to formalise the eventual (unknown) outcome of the
study. We achieve this via the pairs (Ψ,Ω), where Ψ = (Ψ1, . . . ,ΨK)
> and Ω = (Ω1, . . . ,ΩK)> with
• Ψk ∈ {0, 1}, with Ψk = 1 if H0k is rejected, and Ψk = 0 otherwise,
• Ωk ∈ {1, 2}, with Ωk = 1 if following stage one H0k is rejected or accepted, or the whole study is
stopped and no decision is made on H0k, and Ωk = 2 otherwise.
Using this notation, recalling our previous prescription that the rejection of one or more null hypothe-
ses at the interim analysis causes the termination of the entire study, we can define the sample space of
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the random pairs (Ψ,Ω) by
Ξ =
{
(ψ,ω) ∈ {0, 1}K × {1, 2}K : if
K∑
k=1
I(ωk = 1)I(ψk = 1) ≥ 1 then
K∑
k=1
I(ωk = 2) = 0
}
.
Here, I(A) is the indicator function on event A. The following sets will now also be useful
Ξind(k) = {(ψ,ω) ∈ Ξ : I(ψk = 1)} ,
Ξrej =
{
(ψ,ω) ∈ Ξ :
K∑
k=1
I(ψk = 1) > 0
}
,
ΞFWER(p) =
{
(ψ,ω) ∈ Ξ :
K∑
k=1
I(ψk = 1)I(pk = p0) > 0
}
.
These sets represent the subset of outcomes in which a single particular null hypothesis, at least one
null hypothesis, or at least one true null hypothesis, is rejected respectively.
Then, it is the ability to evaluate the probability of observing (Ψ,Ω) = (ψ,ω) on trial completion, for
any vector of success probabilities p, that is key to determining and optimising the considered designs.
Explicitly, referring to this probability as P(ψ,ω|p), we have
P(Reject H0k | p) =
∑
(ψ,ω)∈Ξind(k)
P(ψ,ω|p), (2.2)
FWP (p) =
∑
(ψ,ω)∈Ξrej
P(ψ,ω|p), (2.3)
FWER(p) =
∑
(ψ,ω)∈ΞFWER(p)
P(ψ,ω|p), (2.4)
ESS(p) =
∑
(ψ,ω)∈Ξ
n
(
rCmaxk ωk +
K∑
k=1
rEωk
)
P(ψ,ω|p), (2.5)
where FWP , FWER and ESS are functions that evaluate the FWP, FWER and expected sample size
(ESS) for a given p.
2.2. Exact binomial testing design
In this section, we discuss design based upon exact binomial tests. Jung (2008) and Jung (2013) together
provide detailed discussions on such designs in the case K = 1, and some guidance for K > 1. We expand
on these considerations, providing formulae for computing the FWER, FWP, and ESS of any design, with
any value for K, and early stopping to reject and accept null hypotheses as desired.
In this approach, the goal is to identify suitable values for the parameter n ∈ N+ discussed earlier,
along with acceptance and rejection boundaries f = (f1, f2)
> and e = (e1, e2)> respectively. Informally,
if Tkj ≤ fj we accept H0k, whilst Tkj ≥ ej results in the rejection of H0k. The space of possible designs
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is given by
D =
{
(n,f , e) ∈ Nnmax\Nnmin × Z2 × Z2 : rC2n, rE1n, rE2n ∈ N+, e2 = f2 + 1, f1 < e1 − 1,
f1 ∈ {−rC1n, . . . , rE1n− 2}, e1 ∈ {−rC1n+ 2, . . . , rE1n},
f2 ∈ {f1 + 1− (rC2 − rC1)n, . . . , e1 − 1 + (rE2 − rE1)n}} .
Here, (nmin, nmax) ∈ {(p, q) ∈ N+ × N+ : p ≤ q}, place logical limits on the allowed value of n. These
could be chosen, for example, based on the sample size required by a corresponding single-stage design.
Moreover, the restrictions ensure for any n ∈ N+ that it is possible to stop to accept or reject null
hypotheses at both analyses, and ensure the study terminates after at most two stages. Note that if
it desired to prevent the possibility to reject or accept null hypotheses at the end of stage one, further
restrictions can simply be placed on the set D , with design optimisation then proceeding as below.
Having specified n, f and e, the studies’ formal conduct can be defined, along with the formulae for
P(ψ,ω|p). We provide both in the Appendix. Here, we proceed directly to discussing how values for n,
a and r can be chosen. Specifically, in this instance, it was proposed by Jung (2008) that an optimal
design be determined by exhaustively searching over the set D . Since the evaluation of each design is
independent, parallel execution can be used to enhance the speed of this search. Extending Jung (2013),
we search for the solution to
argmin
(n,a,r)∈D
w1ESS(pESS) + w2ESS(pESS + δ) + w3n(rC2 +KrE2),
subject to α ≥ max
p∈PFWER
FWER(p),
1− β ≤ min
p∈[0,1−maxk δk]
FWP{(p, . . . , p)> + δ},
where w1, w2, w3 ∈ R+ ∪ {0} are weights that indicate which of the three factors we desire to minimise
most. Heeding the advice of Mander et al. (2012), we always ensure that w1 +w2 > 0 since many designs
will likely share the same minimal maximal sample size. Later, we will make use of the notation w =
(w1, w2, w3). Additionally, pESS is a specified vector of success probabilities to utilise in the optimisation
procedure. Typically, this will be those expected under a global null hypotheses pk = p0 for k ∈ N+K .
The two given constraints here are our requirements on the studies’ FWER and FWP. The exact form
of the set PFWER is dependent on whether weak or strong control of the FWER is desired. In the case
where we designate that weak control (i.e., control when all null hypotheses are true) must be achieved,
we set PFWER = {p ∈ [0, 1]K+1 : p = (p, . . . , p)>, p ∈ [0, 1]}. Alternatively, for strong control we must
take PFWER = [0, 1]
K+1.
Note that this contradicts the advice given in Jung (2008), which stated that strong control could be
achieved for the case of two-arm studies by controlling the FWER for p = (0.5, 0.5)>. Although the true
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maximal FWER appears in general to be close to that attained when p = (0.5, 0.5)>, a simple counter
example to it being universally true can be constructed by considering a design with a1, a2 ≤ 0. With such
a design, p = (0, 0)> attains a larger FWER than p = (0.5, 0.5)>. Consequently, a search over one of the
specified PFWER must be included when determining a design. In practice, the multi-dimensional search
required for strong control must be broached by utilising the criteria for weak control during the design
determination stage. Then after choosing an optimal design, a retrospective search over p ∈ [0, 1]K+1
should be performed to argue that strong control has been achieved. Intuitively, it is logical that the
maxima will occur when p ∈ {q ∈ [0, 1]K+1 : q = (q, . . . , q)>, q ∈ [0, 1]}. This type of problem is common
to experiments with binary outcome variables (see, for example, Kunzmann and Kieser (2016)).
With this, the methodology required for determining an optimal design based on exact binomial tests
has been specified. We will later compare this approach to our two-stage Fisher exact test.
2.3. Fisher exact test design
As was discussed, the exact binomial test method summarised above was confirmed to be highly conser-
vative for many combinations of success probabilities, and to address this in a two-arm setting Jung and
Sargent (2014) proposed a two-stage version of Fisher’s exact test. In this section, we detail our extension
to their proposal; allowing for multiple arms and the optimisation of the stopping boundaries.
Our test here is based on the conditional distribution of the Tkl, specified earlier in Equation (2.1),
given the observed total number of successes in each completed stage j ∈ N+2 , zj = x0j + · · · + xKj
(with the unknown total number of stage-wise successes denoted by Zj). To achieve this, we let ρj =
(ρ1j , . . . , ρKj)
>, with ρkj = 1 if arm k is present in the study in stage j, and ρkj = 0 otherwise.
Therefore, note that ρ1 = 1. Then, extending Jung and Sargent (2014), the probability mass function of
xj = (x0j , . . . , xKj)
> conditional on zj , ρj and θ is
f(xj | zj ,ρj ,θ) =
I
(∑K
k=0 xkj = zj
)
h(xj)∑(rCj−rCj−1)n
a0j=0
∑(rEj−rEj−1)n
a1j=0
· · ·∑(rEj−rEj−1)naKj=0 I(∑Kk=0 akj = zj)h(aj) ,
where
h(xj) =
(rCj − rCj−1)n
x0l
 K∏
k=1
ρkj(rEj − rEj−1)n
xkj
 θxkjk ,
and we set 0Cx = I{x = 0}. Note that this immediately implies f(xj | zj ,ρj ,θ) = 0 if
K∑
k=1
I(ρkj = 0)I(xkj > 0) > 0.
Now, the studies’ conduct depends upon having chosen stopping boundaries for all possible total number
of successes that could be observed in stage one and stage two, for every possible number of experimental
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arms that could be present in stage two. Formally, the following are required
• e1z1 , f1 (with e1z1 > f1 + 1) for z1 = 0, . . . , (rC1 +KrE1)n and;
• e2kz2z1 = f2kz2z1+1 for k ∈ N+K , z1 = 0, . . . , (rC1+KrE1)n, z2 = 0, . . . , {(rC2−rC1)+k(rE2−rE1)}n.
Thus, whilst the rejection boundary in stage one depends on the number of observed successes, we have
chosen to simplify matters by making f1 independent of z1, as in Jung and Sargent (2014).
The studies’ formal conduct is then as follows
1. Set ψ = ω = 0.
2. Conduct stage one of the study, allocating rC1n patients to the control arm, and rE1n patients to
each arm k ∈ N+K . Following data accrual, compute z1 and the Tk1.
3. For each k ∈ N+K
• If Tk1 ≥ e1z1 reject H0k, setting ψk = 1 and ωk = 1.
• If Tk1 ≤ f1 accept H0k, setting ωk = 1.
4. If
∑K
k=1 I(ψk = 1) = 0 and
∑K
k=1 I(ωk = 0) > 0, continue to 5. Otherwise stop the study, and for
each k ∈ N+K with ωk = 0, set ωk = 1.
5. Set ρ2 = {I(ω1 = 0), . . . , I(ωK = 0)}>.
6. Conduct stage two of the study, allocating (rC2−rC1)n patients to the control arm, and (rE2−rE1)n
patients to each arm k ∈ N+K with ρk2 = 1. Following data accrual, compute z2 and the Tk2.
7. For each k ∈ N+K with ρk2 = 1
• If Tk2 ≥ e2ρ2·ρ2z2z1 reject H0k, setting ψk = 1 and ωk = 2.
• If Tk2 ≤ f2ρ2·ρ2z2z1 accept H0k, setting ωk = 2.
The above specifies the conduct of our study given values for n, the allocation ratios rCl and rEl,
and the required stopping boundaries. At the design stage of a study though, we require the ability
to choose suitable values for n and the stopping boundaries. The large number of required stopping
boundaries precludes the possibility of optimising every chosen value, as in the method of the previous
section. The aim of the Fisher exact approach though is not to optimise every boundary, but to instead
ensure conditional control of the FWER for all possible values of z1, z2 and ρ2, such that marginal control
is then certain.
However, we can identify designs with more desirable operating characteristics. In Jung (2013) and
Jung and Sargent (2014), the stopping boundaries for stage one were pre-specified, such that only those
for the second stage needed to be chosen. Designing a study in this manner reduces the computational
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complexity of the ensuant optimisation problem. However, it reduces the chance that the operating
characteristics of the resultant design will compare favourably with a design determined using the exact
binomial test approach. Consequently, we here propose a more flexible design framework, reliant on the
specification of two parameters, α1 ∈ (0, α) and β1 ∈ (0, β), that can then be optimised. We first describe
how the stopping boundaries are chosen for any n, given α1 and β1. Following this, we detail how n can
be chosen such that the study attains the desired FWP.
First, for any n, define the function αI1(z1 | r1z1 ,θ) as follows. Precisely, this describes the probability
of committing a familywise error at the end of stage one if z1 success are observed, a rejection boundary
of e1z1 is utilised, and the true vector of odds ratios is θ. We have
αI1(z1 | r1z1 ,θ) =
rC1n∑
x01=0
rE1n∑
x11=0
· · ·
rE1n∑
xK1=0
I
{
K∑
k=1
I(Tk1 ≥ e1z1)I(θk = 1) > 0
}
f(x1 | z1,1,θ).
Motivated by the error spending approach to group sequential trial design, when desiring weak control
of the FWER, we select e1z1 for z1 ∈ {0, . . . , (rC1 + KrE1)n} as the minimal integer for which αI1(z1 |
e1z1 ,1) ≤ α1. Alternatively, for strong control e1z1 is instead the smallest integer such that
max
θ∈(0,∞)K
αI1(z1 | e1z1 ,θ) ≤ α1.
That is, we either weakly or strongly control the possibility of committing a familywise error at the first
analysis to α1.
Next, define
βII1(z1|f1,θ) =
rC1n∑
x01=0
rE1n∑
x11=0
· · ·
rE1n∑
xK1=0
I(T11 ≤ f1)f(x1|z1,1,θ).
We then choose f1 to be the largest integer such that the marginal type-II error rate for H01 at the first
stage, when p = (p, . . . , p)> + δ, is at most β1. That is, f1 is the largest integer such that
max
p∈[0,1−maxk δk]
(rC1+KrE1)n∑
z1=0
βII1[z1|f1,θ{(p, . . . , p)> + δ}]g{z1 | (p, . . . , p)> + δ,1} ≤ β1.
Here g(zj |ρj ,p) is the probability mass function of Zj given ρj and p
g(zj |p,ρj) =
(rCj−rCj−1)n∑
x0j=0
(rEj−rEj−1)n∑
x1j=0
· · ·
(rEj−rEj−1)n∑
xKj=0
I
{
K∑
k=0
xkj = zj
}
b{x0l|(rCj − rCj−1)n, p0}
K∏
k=1
b{xkl|ρkj(rEj − rEj−1)n, pk},
with b(x|n, p) = nCxpx(1− p)n−x.
9
Now, define the function αI2(k, z2, z1|e2kz1z1 , f1, e1z1 ,θ). This evaluates the probability of committing
a familywise error at the end of the second stage, if z1 and z2 successes are observed in stages one and
two respectively, with k experimental arms present in the second stage, conditional on the use of the
stopping boundaries e2kz1z1 , f1, and e1z1 , and a nominated value of θ. Precisely
αI2(k, z2, z1|e2kz1z1 , f1, e1z1 ,θ) =
rC1n∑
x01=0
rE1n∑
x11=0
· · ·
rE1n∑
xK1=0
(rC2−rC1)n∑
x02=0
(rE2−rE1)n∑
x12=0
. . .
(rE2−rE1)n∑
xK2=0
(
I
[
K∑
k1=1
I{Tk11 ∈ (f1, e1z1)} = k
]){
K∏
k2=1
I(Tk21 < e1z1)
}
(
I
[
K∑
k3=1
I{Tk31 ∈ (f1, e1z1)}I{Tk32 ≥ e2kz2z1}I{θk = 1} > 0
])
f(x1|z1,1,θ)f(x2|z2,ρ2,θ),
where ρ2 can be computed from the xk1 and the stopping rules.
Then, to ensure weak control of the FWER we choose e2kz2z1 for k = 1, . . . ,K, z1 = 0, . . . , (rC1 +
KrE1)n, z2 = 0, . . . , [(rC2 − rC1) + k(rE2 − rE1)]n to be the smallest integer such that
αI2(k, z2, z1|e2kz1z1 , f1, e1z1 ,1) ≤
α− αI1(z1 | e1z1 ,1)
K
.
Alternatively, for strong control we must ensure that
max
θ∈(0,∞)K
αI2(k, z2, z1|e2kz1z1 , f1, e1z1 ,θ) ≤
α−maxθ∈(0,∞)K αI1(z1 | e1z1 ,θ)
K
.
Here, division by K in the right-hand side of the above formulae is to allocate the unspent familywise
error equally across the K scenarios defined by the number of arms remaining in the experiment in stage
two.
As in the previous section, for strong control, in practice it is necessary to assume the maximal FWER
occurs on the boundary, and then search for the maximal marginal FWER after design determination.
Note however that weak control is always assured by this design, unlike for the exact binomial test
approach.
We have now fully specified a method for boundary determination given n. With the boundaries
specified, it is then possible to define the formulae for P(ψ,ω|p) in this design. We provide this in the
Appendix. Then, with this formulae ascertained, for any α1 and β1, we can ensure our studies’ FWP
requirement is met by searching for the minimal n ∈ N+ such that
1− β ≤ min
p∈[0,1−maxk δk]
FWP{(p, . . . , p)> + δ}.
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As alluded to previously, we are then free to optimise α1 and β1. Following the previous section, we
minimise
argmin
(α1,β1)∈(0,α)×(0,β)
w1ESS(pESS) + w2ESS(pESS + δ) + w3n(rC2 +KrE2).
Here, we do not need to list constraints on the studies’ operating characteristics as they assured as
part of design determination for any α1 and β1.
Now, since α1 and β1 are continuous variables, this minima could in theory be ascertained by utilising
a conventional greedy optimisation routine. However, there is no guarantee that this would converge
to the global optimum in a parameter space that may contain several local optima, given the discrete
nature of the stopping boundaries and required value for n. One possible solution therefore is to employ
a global continuous optimisation algorithm such as simulated annealing, which has previously been used
with success in clinical trial design (see, for example, Wason and Jaki (2012) and Chan and Lee (2013)).
Such a search is typically a highly time consuming process however. A compromise can be achieved by
instead proposing a set of candidate values for α1 and β1, A1 and B1 respectively. The efficiency of the
designs in A1×B1 can then be evaluated in parallel using a grid-search and what is essentially, depending
on |A1| and |B1|, a near globally optimal design obtained. This method is also advantageous in that the
solution for different combinations of w1, w2 and w3 can be attained simultaneously. In practice, A1
can be specified by choosing a range of equally spaced values with min(A1) ≈ 0 and max(A1) ≈ α, and
similarly for B1. This will be our approach in what follows.
2.4. Example
In this coming section, we determine several example designs using our two-stage Fisher exact procedure,
and compare their performance to those based on the exact binomial method. We reconsider an example
motivated by CALGB 50502; a randomised phase II clinical trial that compared the anti-tumour activity
of two regimens in patients with relapsed/refractory classical Hodgkins lymphoma. With this, we set
α = 0.15, β = 0.2, δ = (0, 0.15, ..., 0.15)>, and pESS = (0.7, . . . , 0.7)
> (Jung, 2008). For simplicity, we
limit our focus to designs with rC2 = 2rC1 = rE2 = 2rE1 = 2.
In determining the designs based on the exact binomial method, we limit the maximal value of n in
our search to 0.75nfixed, where nfixed is the group size required by a corresponding single stage design.
For the designs utilising the Fisher’s exact method, we determine the near optimal design by taking
A1 = {0.01, 0.02, . . . , 0.14}, B1 = {0.01, 0.02, . . . , 0.19}.
Code to replicate our findings is available upon request.
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3. Results
3.1. Comparison of optimised and non-optimised two-stage Fisher exact de-
signs
First, we consider the case with K = 1. Jung and Sargent (2014) designated f1 = −1 and ez11 = dnδ1e+1
for z1 = 0, . . . , 2(K + 1)n in this instance. Here, we compare the efficiency of their design to several
determined using our optimisation procedure. Table 1 presents the ESS for p = pESS = (0.7, 0.7)
> and
p = pESS + δ = (0.7, 0.85)
>, along with the maximal possible sample size, of several designs. Note that
in this instance, the criteria for weak and strong control coincide. Thus strong control is guaranteed by
the Fisher exact approach.
It can be seen that the optimised designs allow the ESS under pESS and pESS+δ to be reduced by up
to 13.1% (w = (1, 0, 0)) and 17.5% (w = (0, 1, 0)) respectively, with only small increases to the maximal
possible sample size. Moreover, one of the optimised designs reduces the maximal sample size by 8.3%
(w = (10−5, 0, 1)), though this comes at a cost to both ESS(pESS) and ESS(pESS + δ). A compromise
can be achieved between reducing the ESSs and the maximal sample size by taking w = (1, 1, 1). In fact,
the design with w = (1, 1, 1) performs better than Jung and Sargent’s design in terms of ESS(pESS),
ESS(pESS + δ), and maxN .
Table 1: A comparison of the design from Jung and Sargent (2014) and several optimised designs for
different values of w1, w2 and w3 is shown. Here, K = 1, pESS = (0.7, 0.7)
>, and δ = (0, 0.15)>.
Design w α1 β1 n ESS(pESS) ESS(pESS + δ) maxN
Jung and Sargent N/A N/A N/A 48 145.49 146.89 192
Optimised
(1, 0, 0) 0.11 0.16 52 126.49 125.42 208
(0, 1, 0)
0.08 0.17 51 126.54 124.93 204
(1, 1, 0)
(10−5, 0, 1) 0.01 0.01 44 162.54 164.60 176
(1, 1, 1)
0.04 0.10 46 131.54 131.27 184(1, 0, 1)
(0, 1, 1)
3.2. Comparison of two-stage Fisher exact and exact binomial test designs
Next, we compare the performance of our proposed two-stage Fisher exact design to that based on the
exact binomial test in the case K = 2. For each approach, we enforce their respective criteria for weak
control of the FWER during design determination.
Searching over A1 × B1 for the Fisher exact approach, in this case the optimal design for each
of w ∈ {(1, 0, 0), (0, 1, 0), (10−5, 0, 1), (1, 1, 0), (1, 0, 1), (0, 1, 1), (1, 1, 1)} is given by the case (α1, β1) =
12
(0.07, 0.17). A summary of this design’s operating characteristics, along with that for the corresponding
optimal designs using the exact binomial test method, are given in Table 2.
Table 2: A summary of several optimal designs for the Fisher and exact binomial test approaches. Here,
K = 2, pESS = (0.7, 0.7, 0.7)
>, and δ = (0, 0.15, 0.15)>.
Design w n f1 e1 f2 ESS(pESS) ESS(pESS + δ) maxN
Fisher exact test All below 38 N/A N/A N/A 154.2 151.7 228
Exact binomial test
(1, 0, 0)
37 2 11 7 144.2 190.3 222
(10−5, 0, 1)
(1, 0, 1)
(1, 1, 1)
(0, 1, 0) 47 4 8 9 158.0 170.5 282
(1, 1, 0) 44 3 8 9 156.3 171.0 264
(0, 1, 1) 38 1 9 8 156.9 181.4 228
We can see that the Fisher exact design attains the smallest value of ESS(pESS + δ), being at least
11% smaller than that for the exact binomial test designs. However, an exact binomial test design does
exist with a smaller value for ESS(pESS). The maximal possible required sample size of the Fisher exact
design is comparable to that of several of the exact binomial test designs.
The operating characteristics of these designs are further elucidated in Figure 1, which depicts the
FWER and ESS when p = (p, . . . , p)> for p ∈ [0, 1], as well as the FWP and ESS when p = (p, . . . , p)>+δ
for p ∈ [0, 0.85].
For more extreme values of p, the Fisher exact design has a FWER closer to the nominal level. There
is however a region around p = 0.5 in which the exact binomial test designs more exhaustively utilise the
allowed FWER. This mirrors the results previously presented for the case with K = 1.
It is clear that the Fisher exact design almost universally has a larger FWP than the exact binomial
test designs. The exact binomial test designs display a characteristic in which the FWP can drop as p
tends towards 0.85. This is a consequence of the fact that the probability of observing a large number of
successes in arm 0 grows more quickly in this region than that for arms 1 and 2.
With the exception of the optimal exact binomial test design for w = (1, 0, 0), the designs require
similar ESSs when p = (p, . . . , p)>. When p = (p, . . . , p)> + δ however, the ESS for the Fisher exact
design is far smaller than that for all of the exact binomial test designs. The fundamental shape of
the ESS curves for the Fisher exact design and the exact binomial test designs in this instance are also
different. This reflects the ability of the Fisher exact test design to alter the rejection boundary when a
large number of successes are observed.
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Figure 1: The operating characteristics of the Fisher exact and exact binomial test designs given in Table
2 are presented. Specifically, in (a) and (c) the familywise error-rate (FWER) and expected sample size
(ESS) when p = (p, . . . , p)> for p ∈ [0, 1] are shown respectively. In (b) and (d) the familywise power
(FWP) and ESS when p = (p, . . . , p)> + δ for p ∈ [0, 0.85] are shown. The Fisher exact design is shown
in red. The optimal exact binomial test designs with w = (1, 0, 0), w = (0, 1, 0), w = (1, 1, 0), and
w = (0, 1, 1), are shown in blue, green, orange, and purple respectively.
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4. Discussion
In this paper, we proposed methodology for the design of a two-stage multi-arm randomised study with
binary outcome variables, based upon Fisher’s exact test. Through several examples, we were able to
demonstrate that pre-specifying the stopping boundaries after stage one reduced potential trial efficiency
substantially. Moreover, we observed that the Fisher exact design typically controlled the FWER more
closely to the nominal level across possible values of the common success probability. In addition, this
design typically retained a power advantage over its binomial exact counterparts, and would be expected
to require a smaller sample size under the global alternative hypothesis. However, in some instances this
did come at a small cost to the examined expected sample size under the global null hypothesis.
In general, the Fisher exact approach is advantageous over the exact binomial test since the common
success probability under the global null hypothesis does not need to be searched over to weakly control
the FWER. However, both methods considered here require a numerical search to control the type-II
error rate to the desired level.
The issues with controlling trial operating characteristics could of course be alleviated by the specifica-
tion of point null and alternative hypotheses. However, in many design situations such an approach may
not be wise. For example, randomised designs have been proposed for phase II clinical trials primarily
to address issues caused by a lack of knowledge about the success probability in the control arm. It is
worth noting that for each of the designs presented in Table 2, we utilised a stochastic search procedure
to search for the maximal FWER across all p ∈ [0, 1]K+1. In each case the maximum appeared to occur,
as anticipated, when p = (p, . . . , p)> for some p ∈ [0, 1]. This suggests strong control can be attained by
controlling the maximal FWER over this p ∈ [0, 1]. A formal proof of this fact remains to be presented
however.
For both of the design procedures considered, it is extremely computationally intensive to determine
the optimal design. Consequently, neither design can be declared preferential based on this factor.
However, as discussed in Jung and Sargent (2014), the Fisher exact approach retains an advantage for
scenarios in which a studies’ sample size differs from its pre-specified value. This can easily be accounted
for, by additionally conditioning on the realised sample sizes.
Throughout, we restricted ourselves to designs in which an equal number of patients were allocated to
each of the experimental arms present in the study. This was necessary for the exact methods considered
here, as unequal allocation would imply that different boundaries would be needed for each of the experi-
mental arms. It is worth noting that the use of a normal approximation for the determination of optimal
two-stage designs could more easily handle differing allocation to the experimental arms. Furthermore,
this approach would readily extend to three-stage designs. Whereas, the exact methods discussed in
this article may be computationally intractable with the addition of a third stage. However, a normal
15
approximation approach would of course not be appropriate in the case of small sample sizes.
In conclusion, we have provided new methodology for the design of multi-arm studies with binary
outcome variables. For the considered example, the operating characteristics of our design were found to
often be preferable to an approach based on exact binomial tests. Thus, whilst there is no golden rule
as to which technique should be preferred, our two-stage Fisher exact test may routinely be expected to
provide more desirable efficiency gains.
Appendix
The formal conduct of a trial utilising the exact binomial test approach is as follows
• Set ψ = ω = 0, and j = 1.
• Conduct stage j of the trial, allocating (rCj−rCj−1)n patients to the control arm, and (rEj−rEj−1)n
patients to each arm k ∈ NK with ωk = 0. Following data accrual, compute the Tkj .
• For each k ∈ NK with ωk = 0
– If Tkj ≥ ej reject H0k, setting ψk = 1 and ωk = j.
– If Tkj ≤ fj accept H0k, setting ωk = j.
• If ∑Kk=1 I{ψk = 1} = 0 and ∑Kk=1 I{ωk = 0} > 0, set j = 2 and return to 2. Otherwise stop the
experiment, and for each k ∈ NK with ωk = 0, set ωk = j.
With this, on trial termination we have that (Ψ,Ω) = (ψ,ω). Then
P(ω,ψ | p) =
rC1n∑
x01=0
rE1n∑
x11=0
· · ·
rE1n∑
xK1=0
(rC2−rC1)n∑
x02=0
(rE2−rE1)n∑
x12=0
. . .
(rE2−rE1)n∑
xK2=0
[
K∏
k1=1
I{Tk11 ∈ BE(k1, 1,ψ,ω)}
][
K∏
k2=1
I{Tk22 ∈ BE(k2, 2,ψ,ω)}
]
{
b(x01|rC1n, p0)
K∏
k3=1
b(xk31|rE1n, pk3)
}
[
b{x02|(rC2 − rC1)n, p0}
K∏
k4=1
b{xk42|(rE2 − rE1)n, pk4}
]
,
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where
BE(k, j,ψ,ω) =

(f1, e1) : j < ωk,
(−∞,∞) : j > ωk,
[ej ,∞) : j = ωk, ψk = 1,
(−∞, ej − 1] : j = ωk = maxl ωl, ψk = 0,
∑
l I(ψl = 1) > 0,
(−∞, fj ] : otherwise.
Similarly, for the Fisher exact test design
P(ω,ψ | p) =
rC1n∑
x01=0
rE1n∑
x11=0
· · ·
rE1n∑
xK1=0
(rC2−rC1)n∑
x02=0
(rE2−rE1)n∑
x12=0
. . .
(rE2−rE1)n∑
xK2=0
[
K∏
k1=1
I{Tk11 ∈ BF1(k1, z1,ψ,ω)}
][
K∏
k2=1
I{Tk22 ∈ BF2(k2, z1, z2,ρ2,ψ,ω)}
]
{
b(x01|rC1n, p0)
K∏
k3=1
b(xk31|rE1n, pk3)
}
[
b{x02|(rC2 − rC1)n, p0}
K∏
k4=1
b{xk42|(rE2 − rE1)n, pk4}
]
,
where
BF1(k, z1,ψ,ω) =

(f1, e1z1) : ωk = 2,
[e1z1 ,∞) : ωk = ψk = 1,
(−∞, f1] : ωk = 1 = maxl ωl,
∏
l I(ψl = 0) = 1,
(−∞, e1z1 − 1] : ωk = 1 = maxl ωl, ψk = 0,
∏
l I(ψl = 0) = 0,
BF2(k, z1, z2,ρ2,ψ,ω) =

(−∞,∞) : ωk = 1,
[e2ρ2·ρ2z2z1 ,∞) : ωk = 2, ψk = 1,
(−∞, f2ρ2·ρ2z2z1 ] : ωk = 2, ψk = 0.
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